PTGS2 and cancer: Elevated COX-2 expression is often associated with a poor prognosis in numerous cancers including melanoma [182,183,184] and has been linked to increased cell proliferation and invasion via activation of signaling pathways, playing a critical role in melanoma progression, such as the MAPK, the β-catenin and the EGFR/PI3K pathways.